Sign In
Buy OMER
$10.16
-0.1000 (-0.97%)
At Close: Jun 03, 2026
Here's Why Omeros Is Sinking Further Today
12:24pm, Monday, 18'th Oct 2021
Bad news the company received today from the FDA surprised investors more than it probably should have.
OMER Stock: Why The Price Fell Today
07:16am, Monday, 18'th Oct 2021
The stock price of Omeros Corporation (NASDAQ: OMER) fell by over 16% pre-market today. This is why it happened.
Omeros Receives Complete Response Letter from FDA for Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA
06:30am, Monday, 18'th Oct 2021
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Bi
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
09:45pm, Friday, 15'th Oct 2021
NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Omeros Corporation ("Omeros" or the "Company") (NASDAQ: OMER). Such investors are advised
NEW YORK--(BUSINESS WIRE)-- #Omeros--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Omeros Corporation (“Omeros” or the
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Omeros Corporatio
LOS ANGELES, Oct. 7, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Omeros Corporation ("O
LOS ANGELES--(BUSINESS WIRE)---- $OMER #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Omeros Corporation (OMER) on Behalf of Investors
04:51pm, Tuesday, 05'th Oct 2021
BENSALEM, Pa.--(BUSINESS WIRE)---- $OMER #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of Omeros Corporation (“Omeros” or the “Company”) (NASDAQ: OMER) inve
LOS ANGELES--(BUSINESS WIRE)---- $OMER #OMER--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Omeros Corporation.
LOS ANGELES--(BUSINESS WIRE)---- $OMER #OMER--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Omeros Corporation.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
05:02pm, Friday, 01'st Oct 2021
New York, New York--(Newsfile Corp. - October 1, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Omeros Corporation ("Omeros" or the "Company") (NASDAQ: OMER). Such investors
OMER Stock Price: Why It Substantially Fell Today
03:00pm, Friday, 01'st Oct 2021
The stock price of Omeros Corporation (Nasdaq: OMER) fell by over 39% during intraday trading today. This is why it happened.
OMER Stock: Why Little-Known Omeros Is Absolutely Plunging Today
02:03pm, Friday, 01'st Oct 2021
Today, some rather unfortunate news has come to light regarding one of Omeros' prospective drugs, taking OMER stock 40% lower. The post OMER Stock: Why Little-Known Omeros Is Absolutely Plunging Today
Here's why Omeros Corp shares are down 40% on Friday morning
12:11pm, Friday, 01'st Oct 2021
The U.S. FDA notified Omeros Corporation (NASDAQ: OMER) that it identified deficiencies in the company's marketing application for Narsoplimab, Omeros disclosed in a press release this morning. Sha
